QRL-101-03 (NCT06532396) is a randomized, double-blind, placebo-controlled, multiple-ascending dose clinical trial evaluating the safety, tolerability, and PK of QRL-101 in up to 60 healthy ...
The American Academy of Neurology (AAN), the American Epilepsy Society (AES) and the Epilepsy Foundation of America (EFA) have issued a ...
New seizure and driving guidelines emphasize medical boards for licensing decisions and give physicians more flexibility and ...
The American Academy of Neurology (AAN), the American Epilepsy Society (AES) and the Epilepsy Foundation of America (EFA) have issued a consensus position statement on seizures, driver licensure and ...
An emerging type of artificial intelligence could improve the detection of seizures in epilepsy patients thanks to its ...
Naomi Leigh, 23, began feeling unwell during her first year studying occupational therapy at university and later discovered ...
An emerging type of artificial intelligence could improve the detection of seizures in epilepsy patients thanks to its ...
The American Academy of Neurology (AAN), the American Epilepsy Society (AES) and the Epilepsy Foundation of America (EFA) have issued a consensus position statement on seizures, driver licensure and ...
Epilepsy diagnosis is an imperfect science. Approximately 30% of patients are misdiagnosed after their first visit.
2025 — Doctors could soon reduce epilepsy misdiagnoses by up to 70% using a new tool that turns routine electroencephalogram, or EEG, tests that appear normal into highly accurate epilepsy ...
After multiple trips into Geelong hospital, Charlotte was diagnosed with epilepsy. She was put on medication that kept her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback